Vascular dementia

Clinical Neuroscience Research

Volumn 3, Issue 6, 2004, Pages 437-448

  Desmond, David W ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

Alzheimer's disease; Cerebrovascular disease; Dementia; Stroke; Vascular dementia

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; APOLIPOPROTEIN E4; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DONEPEZIL; GALANTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; MEMANTINE; NEUROPROTECTIVE AGENT; NIMODIPINE; RIVASTIGMINE; TACRINE; WARFARIN;

AGE DISTRIBUTION; ALLELE; ALZHEIMER DISEASE; ASIA; BRAIN DYSFUNCTION; CADASIL; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; EDUCATION; FAMILIAL DISEASE; HUMAN; LEFT HEMISPHERE; LONGEVITY; MEDICAL PRACTICE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; WESTERN HEMISPHERE;

EID: 2542456748     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2004.04.009     Document Type: Article

References (157)

1. Sloane P.D. Zimmerman S. Suchindran C. et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances Annu Rev Public Health 23 2002 213-231
2. Pohjasvaara T. Erkinjuntti T. Vataja R. Kaste M. Correlates of dependent living 3 months after ischemic stroke Cerebrovasc Dis 8 1998 259-266
3. Moroney J.T. Bagiella E. Tatemichi T.K. Paik M.C. Stern Y. Desmond D.W. Dementia after stroke increases the risk of long-term stroke recurrence Neurology 48 1997 1317-1325
4. Mölsä P.K. Marttila R.J. Rinne U.K. Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia Acta Neurol Scand 91 1995 159-164
5. Desmond D.W. Moroney J.T. Sano M. Stern Y. Mortality in patients with dementia after ischemic stroke Neurology 59 2002 537-543
6. Knopman D.S. Rocca W.A. Cha R.H. Edland S.D. Kokmen E. Survival study of vascular dementia in Rochester, Minnesota Arch Neurol 60 2003 85-90
7. Lobo A. Launer L.J. Fratiglioni L. et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts Neurology 54 Suppl 5 2000 S4-S9
8. Ueda K. Kawano H. Hasuo Y. Fujishima M. Prevalence and etiology of dementia in a Japanese community Stroke 23 1992 798-803
9. Ikeda M. Hokoishi K. Maki N. et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study Neurology 57 2001 839-844
10. Kiyohara Y. Yoshitake T. Kato I. et al. Changing patterns in the prevalence of dementia in a Japanese community: the Hisayama study Gerontology 40 Suppl 2 1994 29-35
11. American Psychiatric Association Diagnostic and statistical manual of mental disorders 3rd edition, revised 1987 American Psychiatric Association Washington, DC
12. Román G.C. Tatemichi T.K. Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250-260
13. Desmond D.W. Moroney J.T. Paik M.C. et al. Frequency and clinical determinants of dementia after ischemic stroke Neurology 54 2000 1124-1131
14. Pohjasvaara T. Erkinjuntti T. Ylikoski R. Hietanen M. Vataja R. Kaste M. Clinical determinants of poststroke dementia Stroke 29 1998 75-81
15. Barba R. Mart́nez-Espinosa S. Rodŕguez-Garća E. Pondal M. Vivancos J. Del Ser T. Poststroke dementia. Clinical features and risk factors Stroke 31 2000 1494-1501
16. Erkinjuntti T. Østbye T. Steenhuis R. Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia N Engl J Med 337 1997 1667-1674
17. Desmond D.W. Moroney J.T. Bagiella E. Sano M. Stern Y. Dementia as a predictor of adverse outcomes following stroke: an evaluation of diagnostic methods Stroke 29 1998 69-74
18. Desmond D.W. Bagiella E. Moroney J.T. Stern Y. The effect of patient attrition on estimates of the frequency of dementia following stroke Arch Neurol 55 1998 390-394
19. Hachinski V. Vascular dementia: a radical redefinition Dementia 5 1994 130-132
20. Petersen R.C. Doody R. Kurz A. et al. Current concepts in mild cognitive impairment Arch Neurol 58 2001 1985-1992
21. Rockwood K. Howard K. MacKnight C. Darvesh S. Spectrum of disease in vascular cognitive impairment Neuroepidemiology 18 1999 248-254
22. Wentzel C. Rockwood K. MacKnight C. et al. Progression of impairment in patients with vascular cognitive impairment without dementia Neurology 57 2001 714-716
23. Rockwood K. Wentzel C. Hachinski V. Hogan D.B. MacKnight C. McDowell I. Prevalence and outcomes of vascular cognitive impairment Neurology 54 2000 447-451
24. Censori B. Manara O. Agostinis C. et al. Dementia after first stroke Stroke 27 1996 1205-1210
25. Van Bogaert L. Encéphalopathie sous-corticale progressive (Binswanger) à évolution rapide chez deux soeurs Med Hellen 24 1955 961-972
26. Sourander P. Wålinder J. Hereditary multi-infarct dementia: morphological and clinical studies of a new disease Acta Neuropathol 39 1977 247-254
27. Tournier-Lasserve E. Joutel A. Melki J. et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12 Nat Genet 3 1993 256-259
28. Chabriat H. Vahedi K. Iba-Zizen M.T. et al. Clinical spectrum of CADASIL: a study of 7 families Lancet 346 1995 934-939
29. Davous P. CADASIL: a review with proposed diagnostic criteria Eur J Neurol 5 1998 219-233
30. Dichgans M. Mayer M. Uttner I. et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases Ann Neurol 44 1998 731-739
31. Desmond D.W. Moroney J.T. Lynch T. Chan S. Chin S.S. Mohr J.P. The natural history of CADASIL. A pooled analysis of previously published cases Stroke 30 1999 1230-1233
32. Desmond D.W. Moroney J.T. Lynch T. et al. CADASIL in a North American family: clinical, pathologic, and radiologic findings Neurology 51 1998 844-849
33. Chabriat H. Levy C. Taillia H. et al. Patterns of MRI lesions in CADASIL Neurology 51 1998 452-457
34. Markus H.S. Martin R.J. Simpson M.A. et al. Diagnostic strategies in CADASIL Neurology 59 2002 1134-1138
35. Ruchoux M.M. Maurage C.A. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy J Neuropathol Exp Neurol 56 1997 947-964
36. Joutel A. Corpechot C. Ducros A. et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia Nature 383 1996 707-710
37. Mayeux R. Gene-environment interaction in late-onset Alzheimer disease: the role of apolipoprotein-E4 Alzheimer Dis Assoc Disord 12 Suppl 3 1998 S10-S15
38. Pedro-Botet J. Sent́ M. Nogués X. et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism Stroke 23 1992 1556-1562
39. Slooter A.J.C. Tang M.X. van Duijn C.M. et al. Apolipoprotein E E4 and the risk of dementia with stroke. A population-based investigation J Am Med Assoc 277 1997 818-821
40. Treves T.A. Bornstein N.M. Chapman J. et al. APOE-E4 in patients with Alzheimer disease and vascular dementia Alzheimer Dis Assoc Disord 10 1996 189-191
41. Katzman R. Zhang M.Y. Chen P.J. et al. Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia Neurology 49 1997 779-785
42. Ji Y. Urakami K. Adachi Y. Maeda M. Isoe K. Nakashima K. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease Dement Geriatr Cogn Disord 9 1998 243-245
43. Marin D.B. Breuer B. Marin M.L. et al. The relationship between apolipoprotein E, dementia, and vascular illness Atherosclerosis 140 1998 173-180
44. Hébert R. Lindsay J. Verreault R. Rockwood K. Hill G. Dubois M.F. Vascular dementia: incidence and risk factors in the Canadian Study of Health and Aging Stroke 31 2000 1487-1493
45. Moroney J.T. Tang M.X. Berglund L. et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke J Am Med Assoc 282 1999 254-260
46. Nakayama S. Kuzuhara S. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan Psychiatry Clin Neurosci 53 1999 643-648
47. Molero A.E. Pino-Raḿrez G. Maestre G.E. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-E4 allele in Latin Americans: findings from the Maracaibo Aging Study Neurosci Lett 307 2001 5-8
48. Frank A. Diez-Tejedor E. Bullido M.J. Valdivieso F. Barreiro P. APOE genotype in cerebrovascular disease and vascular dementia J Neurol Sci 203-204 2002 173-176
49. Gearing M. Mirra S.S. Hedreen J.C. Sumi S.M. Hansen L.A. Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease Neurology 45 1995 461-466
50. Bowler J.V. Munoz D.G. Merskey H. Hachinski V. Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease J Neurol Neurosurg Psychiatry 64 1998 18-24
51. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales Lancet 357 2001 169-175
52. Hénon H. Pasquier F. Durieu I. et al. Preexisting dementia in stroke patients: baseline frequency, associated factors, and outcome Stroke 28 1997 2429-2436
53. Heyman A. Fillenbaum G.G. Welsh-Bohmer K.A. et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease. CERAD, part XVIII Neurology 51 1998 159-162
54. Snowdon D.A. Greiner L.H. Mortimer J.A. Riley K.P. Greiner P.A. Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study J Am Med Assoc 277 1997 813-817
55. Moroney J.T. Bagiella E. Hachinski V.C. et al. Misclassification of dementia subtype using the Hachinski Ischemic Score: results of a meta-analysis of patients with pathologically verified dementias Ann NY Acad Sci 826 1997 490-492
56. Meyer J.S. Muramatsu K. Mortel K.F. Obara K. Shirai T. Prospective C.T. confirms differences between vascular and Alzheimer's dementia Stroke 26 1995 735-742
57. Desmond D.W. Erkinjuntti T. Sano M. et al. The cognitive syndrome of vascular dementia: implications for clinical trials Alzheimer Dis Assoc Disord 13 Suppl 3 1999 S21-S29
58. Looi J.C.L. Sachdev P.S. Differentiation of vascular dementia from AD on neuropsychological tests Neurology 53 1999 670-678
59. Tei H. Miyazaki A. Iwata M. Osawa M. Nagata Y. Maruyama S. Early-stage Alzheimer's disease and multiple subcortical infarction with mild cognitive impairment: neuropsychological comparison using an easily applicable test battery Dement Geriatr Cogn Disord 8 1997 355-358
60. Reichman W. Cummings J.L. McDaniel K.D. Flynn F. Gornbein J. Visuoconstructional impairment in dementia syndromes Behav Neurology 4 1991 153-162
61. Walker M.P. Ayre G.A. Cummings J.L. et al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia Neurology 54 2000 1616-1625
62. Villardita C. Alzheimer's disease compared with cerebrovascular dementia: neuropsychological similarities and differences Acta Neurol Scand 87 1993 299-308
63. Kertesz A. Clydesdale S. Neuropsychological deficits in vascular dementia vs Alzheimer's disease: frontal lobe deficits prominent in vascular dementia Arch Neurol 51 1994 1226-1231
64. Starkstein S.E. Sabe L. Vazquez S. et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease Stroke 27 1996 408-414
65. Almkvist O. Backman L. Basun H. Wahlund L.O. Patterns of neuropsychological performance in Alzheimer's disease and vascular dementia Cortex 29 1993 661-673
66. Mendez M.F. Cherrier M.M. Perryman K.M. Differences between Alzheimer's disease and vascular dementia on information processing measures Brain Cogn 34 1997 301-310
67. Mendez M.F. Ashla-Mendez M. Differences between multi-infarct dementia and Alzheimer's disease on unstructured neuropsychological tasks J Clin Exp Neuropsychol 13 1991 923-932
68. Doody R.S. Massman P.J. Mawad M. Nance M. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia Neuropsychiatry Neuropsychol Behav Neurol 11 1998 191-199
69. Padovani A. Di Piero V. Bragoni M. Iacoboni M. Gualdi G.F. Lenzi G.L. Patterns of neuropsychological impairment in mild dementia: a comparison between Alzheimer's disease and multi-infarct dementia Acta Neurol Scand 92 1995 433-442
70. Lafosse J.M. Reed B.R. Mungas D. Sterling S.B. Wahbeh H. Jagust W.J. Fluency and memory differences between ischemic vascular dementia and Alzheimer's disease Neuropsychology 11 1997 514-522
71. Libon D.J. Bogdanoff B. Bonavita J. et al. Dementia associated with periventricular and deep white matter alterations: a subtype of subcortical dementia Arch Clin Neuropsychol 12 1997 239-250
72. Tierney M.C. Black S.E. Szalai J.P. et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia Arch Neurol 58 2001 1654-1659
73. Powell A.L. Cummings J.L. Hill M.A. Benson D.F. Speech and language alterations in multi-infarct dementia Neurology 38 1988 717-719
74. Lamar M. Podell K. Carew T.G. et al. Perseverative behavior in Alzheimer's disease and subcortical ischemic vascular dementia Neuropsychology 11 1997 523-534
75. Traykov L. Baudic S. Thibaudet M.C. Rigaud A.S. Smagghe A. Boller F. Neuropsychological deficit in early subcortical vascular dementia: comparison to Alzheimer's disease Dement Geriatr Cogn Disord 14 2002 26-32
76. Loewenstein D.A. D'Elia L. Guterman A. et al. The occurrence of different intrusive errors in patients with Alzheimer's disease, multiple cerebral infarctions, and major depression Brain Cogn 16 1991 104-117
77. Barr A. Benedict R. Tune L. Brandt J. Neuropsychological differentiation of Alzheimer's disease from vascular dementia Int J Geriatr Psychiatry 7 1992 621-627
78. Del Re M.L. Pennese F. Ciurlino P. Abate G. Analysis of verbal memory and learning by means of selective reminding procedure in Alzheimer and multi-infarct dementias Aging 5 1993 185-192
79. Carlesimo G.A. Sabbadini M. Fadda L. Caltagirone C. Forgetting from long-term memory in dementia and pure amnesia: role of task, delay of assessment and aetiology of cerebral damage Cortex 31 1995 285-300
80. Hassing L. Bäckman L. Episodic memory functioning in population-based samples of very old adults with Alzheimer's disease and vascular dementia Dement Geriatr Cogn Disord 8 1997 376-383
81. Carlesimo G.A. Fadda L. Bonci A. Caltagirone C. Differential rates of forgetting from long-term memory in Alzheimer's and multi-infarct dementia Int J Neurosci 73 1993 1-11
82. Pasquier F. Jacob B. Lefebvre L. Grymonprez L. Debachy B. Petit H. How to evaluate cognitive dysfunction in patients with vascular dementia? In: Leys D. Scheltens P. (Eds.), Vascular dementia 1994 47-53 ICG Publications Dordrecht, The Netherlands
83. Yuspeh R.L. Vanderploeg R.D. Kershaw D.A. Validity of a semantically cued recall procedure for the mini-mental state examination Neuropsychiatry Neuropsychol Behav Neurol 11 1998 207-211
84. Fuld P.A. Katzman R. Davies P. Terry R.D. Intrusions as a sign of Alzheimer dementia: chemical and pathological verification Ann Neurol 11 1982 155-159
85. Hier D.B. Hagenlocker K. Shindler A.G. Language disintegration in dementia: effects of etiology and severity Brain Lang 25 1985 117-133
86. Erkinjuntti T. Laaksonen R. Sulkava R. Syrjalainen R. Palo J. Neuropsychological differentiation between normal aging, Alzheimer's disease and vascular dementia Acta Neurol Scand 74 1986 393-403
87. Reed B.R. Eberling J.L. Mungas D. Weiner M.W. Jagust W.J. Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease Ann Neurol 48 2000 275-284
88. Erkinjuntti T. Inzitari D. Pantoni L. et al. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann NY Acad Sci 903 2000 262-272
89. Erkinjuntti T. Inzitari D. Pantoni L. et al. Research criteria for subcortical vascular dementia in clinical trials J Neural Transm 107 Suppl 59 2000 23-30
90. Wolfe N. Linn R. Babikian V.L. Knoefel J.E. Albert M.L. Frontal systems impairment following multiple lacunar infarcts Arch Neurol 47 1990 129-132
91. Cummings J.L. Vascular subcortical dementias: clinical aspects Dementia 5 1994 177-180
92. Desmond D.W. The evaluation of mood and behavior in patients with focal brain lesions In: Bogousslavsky J. Cummings J.L. (Eds.), Behavior and mood disorders in focal brain lesions 2000 21-47 Cambridge University Press Cambridge, England
93. Bogousslavsky J. Regli F. Uske A. Thalamic infarcts: clinical syndromes, etiology, and prognosis Neurology 38 1988 837-848
94. Caplan L.R. Schmahmann J.D. Kase C.S. et al. Caudate infarcts Arch Neurol 47 1990 133-143
95. Desmond D.W. Tatemichi T.K. Mohr J.P. Clinical and neuropsychological findings following anterior thalamic infarction Ann Neurol 36 1994 304
96. Tatemichi T.K. Desmond D.W. Prohovnik I. et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 42 1992 1966-1979
97. Tatemichi T.K. Desmond D.W. Prohovnik I. Strategic infarcts in vascular dementia: a clinical and brain imaging experience Drug Res 45 1995 371-385
98. Hachinski V.C. Lassen N.A. Marshall J. Multi-infarct dementia: a cause of mental deterioration in the elderly Lancet 2 1974 207-210
99. Brust J.C.M. Dementia and cerebrovascular disease In: Mayeux R. Rosen W.G. (Eds.), The dementias 1983 131-147 Raven Press New York
100. Cummings J.L. Multi-infarct dementia: diagnosis and management Psychosomatics 28 1987 117-126
101. Loeb C. Clinical criteria for the diagnosis of vascular dementia Eur Neurol 28 1988 87-92
102. Luria A.R. The working brain: an introduction to neuropsychology 1973 Basic Books New York
103. Sulkava R. Erkinjuntti T. Vascular dementia due to cardiac arrhythmias and systemic hypotension Acta Neurol Scand 76 1987 123-128
104. Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology Dementia 5 1994 145-147
105. Desmond D.W. Moroney J.T. Sano M. Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study Stroke 33 2002 2254-2260
106. Fisher M. Senile dementia - a new explanation of its causation Can Med Assoc J 65 1951 1-7
107. Paulson G.W. Kapp J. Cook W. Dementia associated with bilateral carotid artery disease Geriatrics 21 1966 159-166
108. Ferguson G.G. Peerless S.J. Extracranial-intracranial arterial bypass in the treatment of dementia and multiple extracranial arterial occlusion Stroke 7 1976 13
109. Leblanc R. Tyler J.L. Mohr G. et al. Hemodynamic and metabolic effects of cerebral revascularization J Neurosurg 66 1987 529-535
110. Abiko S. Matsunaga T. Yamashita T. Fujii M. Aoki H. Anastomosis of the superficial temporal artery to the middle cerebral artery for occlusive disease of the bilateral internal carotid arteries with dementia No Shinkei Geka 18 1990 1047-1052
111. Yanagihara T. Marsh W.R. Piepgras D.G. Ivnik R.J. Dementia in bilateral carotid occlusive disease Stroke 21 Suppl 1 1990 I-99
112. Tatemichi T.K. Desmond D.W. Prohovnik I. Eidelberg D. Dementia associated with bilateral carotid occlusions: neuropsychological and haemodynamic course after extracranial to intracranial bypass surgery J Neurol Neurosurg Psychiatry 58 1995 633-636
113. Itoh Y. Yamada M. Hayakawa M. Otomo E. Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly J Neurol Sci 116 1993 135-141
114. Joachim C.L. Morris J.H. Selkoe D.J. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases Ann Neurol 24 1988 50-56
115. Ellis R.J. Olichney J.M. Thal L.J. et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience. Part XV Neurology 46 1996 1592-1596
116. Schmidt R. Fazekas F. Offenbacher H. et al. Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers Neurology 43 1993 2490-2494
117. Breteler M.M.B. van Amerongen N.M. van Swieten J.C. et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study Stroke 25 1994 1109-1115
118. DeCarli C. Murphy D.G.M. Tranh M. et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults Neurology 45 1995 2077-2084
119. Longstreth W.T. Manolio T.A. Arnold A. et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study Stroke 27 1996 1274-1282
120. Boone K.B. Miller B.L. Lesser I.M. et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect Arch Neurol 49 1992 549-554
121. de Groot J.C. de Leeuw F.E. Oudkerk M. et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study Ann Neurol 47 2000 145-151
122. Ylikoski R. Ylikoski A. Erkinjuntti T. Sulkava R. Raininko R. Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing Arch Neurol 50 1993 818-824
123. Fukui T. Sugita K. Sato Y. Takeuchi T. Tsukagoshi H. Cognitive functions in subjects with incidental cerebral hyperintensities Eur Neurol 34 1994 272-276
124. Tatemichi T.K. Foulkes M.A. Mohr J.P. et al. Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings Stroke 21 1990 858-866
125. Yoshitake T. Kiyohara Y. Kato I. et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study Neurology 45 1995 1161-1168
126. Bornstein N.M. Gur A.Y. Treves T.A. et al. Do silent brain infarctions predict the development of dementia after first ischemic stroke? Stroke 27 1996 904-905
127. Zhu L. Fratiglioni L. Guo Z. et al. Incidence of dementia in relation to stroke and the apolipoprotein E E4 allele in the very old. Findings from a population-based longitudinal study Stroke 31 2000 53-60
128. Di Carlo A. Baldereschi M. Amaducci L. et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study J Am Geriatr Soc 50 2002 41-48
129. Knopman D.S. Rocca W.A. Cha R.H. Edland S.D. Kokmen E. Incidence of vascular dementia in Rochester, Minn, 1985-1989 Arch Neurol 59 2002 1605-1610
130. Cooper J. Mungas D. Risk factor and behavioural differences between vascular and Alzheimer's dementias: the pathway to end-stage disease J Geriatr Psychiatry Neurol 6 1993 29-33
131. Stern Y. Liu X. Albert M. et al. Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease Arch Neurol 53 1996 1121-1126
132. Stern Y. Liu X. Albert M. et al. Application of a growth curve approach to modeling the progression of Alzheimer's disease J Gerontol A Biol Sci Med Sci 51 1996 M179-M184
133. Loeb C. Gandolfo C. Croce R. Conti M. Dementia associated with lacunar infarction Stroke 23 1992 1225-1229
134. Fischer P. Gatterer G. Marterer A. Simanyi M. Danielczyk W. Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia Acta Psychiatr Scand 81 1990 551-553
135. Moroney J.T. Bagiella E. Desmond D.W. et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias Neurology 49 1997 1096-1105
136. Fillit H. Hill J. The costs of vascular dementia: a comparison with Alzheimer's disease J Neurol Sci 203-204 2002 35-39
137. Rockwood K. Brown M. Merry H. Sketris I. Fisk J. Societal costs of vascular cognitive impairment in older adults Stroke 33 2002 1605-1609
138. Ferrucci L. Guralnik J.M. Salive M.E. et al. Cognitive impairment and risk of stroke in the older population J Am Geriatr Soc 44 1996 237-241
139. Goldstein L.B. Adams R. Becker K. et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association Stroke 32 2001 280-299
140. Moroney J.T. Tseng C.L. Paik M.C. Mohr J.P. Desmond D.W. Treatment for the secondary prevention of stroke in older patients: the influence of dementia status J Am Geriatr Soc 47 1999 824-829
141. Ott A. Stolk R.P. Hofman A. van Harskamp F. Grobbee D.E. Breteler M.M.B. Association of diabetes mellitus and dementia: the Rotterdam Study Diabetologia 39 1996 1392-1397
142. Skoog I. Lernfelt B. Landahl S. et al. 15-year longitudinal study of blood pressure and dementia Lancet 347 1996 1141-1145
143. Ott A. Breteler M.M.B. de Bruyne M.C. van Harskamp F. Grobbee D.E. Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study Stroke 28 1997 316-321
144. Dooley M. Lamb H.M. Donepezil: a review of its use in Alzheimer's disease Drugs Aging 16 2000 199-226
145. Moretti R. Torre P. Antonello R.M. Cazzato G. Bava A. Rivastigmine in subcortical vascular dementia: an open 22-month study J Neurol Sci 203-204 2002 141-146
146. Erkinjuntti T. Kurz A. Gauthier S. Bullock R. Lilienfeld S. Damaraju C.V. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial Lancet 359 2002 1283-1290
147. Orgogozo J.M. Rigaud A.S. Stöffler A. Möbius H.J. Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300) Stroke 33 2002 1834-1839
148. Wilcock G. Möbius H.J. Stöffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500) Int Clin Psychopharmacol 17 2002 297-305
149. Jick H. Zornberg G.L. Jick S.S. Seshadri S. Drachman D.A. Statins and the risk of dementia Lancet 356 2000 1627-1631
150. Wolozin B. Kellman W. Ruosseau P. Celesia G.G. Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors Arch Neurol 57 2000 1439-1443
151. López-Arrieta J.M. Birks J. Nimodipine for primary degenerative, mixed and vascular dementia Cochrane Database Syst Rev CD000147 2002
152. Pantoni L. Rossi R. Inzitari D. et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial J Neurol Sci 175 2000 124-134
153. Pantoni L. Bianchi C. Beneke M. Inzitari D. Wallin A. Erkinjuntti T. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia J Neurol Sci 175 2000 116-123
154. McGeer P.L. Schulzer M. McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies Neurology 47 1996 425-432
155. in t' Veld B.A. Ruitenberg A. Hofman A. et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease N Engl J Med 345 2001 1515-1521
156. Sano M. Ernesto C. Thomas R.G. et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease N Engl J Med 336 1997 1216-1222
157. Engelhart M.J. Geerlings M.I. Ruitenberg A. et al. Dietary intake of antioxidants and risk of Alzheimer disease J Am Med Assoc 287 2002 3223-3229